{"id":809,"date":"2026-10-19T08:27:10","date_gmt":"2026-10-19T06:27:10","guid":{"rendered":"https:\/\/www.pqra.gr\/change-control-in-the-pharmaceutical-quality-system-linking-quality-to-regulatory-impact\/"},"modified":"2026-10-19T09:51:25","modified_gmt":"2026-10-19T07:51:25","slug":"change-control-in-the-pharmaceutical-quality-system-linking-quality-to-regulatory-impact","status":"publish","type":"post","link":"https:\/\/www.pqra.gr\/el\/change-control-in-the-pharmaceutical-quality-system-linking-quality-to-regulatory-impact\/","title":{"rendered":"Change Control in the Pharmaceutical Quality System: Linking Quality to Regulatory Impact"},"content":{"rendered":"<p style=\"font-size:19px;line-height:1.7;color:#33414d;\"><strong>A change that is well controlled on site can still create a compliance problem if nobody asked whether the marketing authorisation needs to be updated first.<\/strong><\/p>\n<h2>The purpose of change control<\/h2>\n<p>Change control provides a structured way to evaluate, approve and implement changes to processes, equipment, materials, methods, systems and documents. ICH Q10 treats change management as a core element of the quality system, intended to ensure that changes are evaluated by expert teams, supported by science and risk, and assessed for their effect on product quality across the lifecycle.<\/p>\n<h2>Essential steps<\/h2>\n<ul><li>Describe the change and the reason for it.<\/li><li>Assess impact on product quality, validation status, stability, supply and documentation.<\/li><li>Assess regulatory impact against the approved dossier and the applicable variations framework.<\/li><li>Define actions, testing and validation needed before implementation.<\/li><li>Obtain cross-functional approval, including quality and regulatory affairs.<\/li><li>Implement, verify and close with evidence that the change achieved its aim.<\/li><\/ul>\n<h2>The regulatory gate<\/h2>\n<p>Where the change affects something described in the authorised dossier, such as a manufacturing site, process, specification, packaging or shelf life, it may require a variation, and implementation has to wait for the appropriate notification or approval. Building a regulatory classification step into the change form prevents the costly situation of a change implemented in production but not yet reflected in the authorisation.<\/p>\n<h2>Planned, temporary and emergency changes<\/h2>\n<p>Emergency or temporary changes still need documented control, with retrospective review in a defined time. Overuse of the emergency route is a warning sign that planning is failing.<\/p>\n<h2>Effectiveness and trending<\/h2>\n<p>After implementation, check that the change delivered the intended outcome and caused no harm. Trending change volumes, delays and reasons gives management early warning of weaknesses in the underlying processes and feeds the management review.<\/p>\n<h2>Related reading<\/h2>\n<ul><li><a href=\"https:\/\/www.pqra.gr\/el\/document-control-in-a-pharmaceutical-qms-hierarchy-versions-and-the-draft-eu-chapter-4\/\">Document Control in a Pharmaceutical QMS: Hierarchy, Versions and the Draft EU Chapter 4<\/a><\/li><li><a href=\"https:\/\/www.pqra.gr\/el\/management-review-under-ich-q10-turning-quality-data-into-decisions\/\">Management Review Under ICH Q10: Turning Quality Data Into Decisions<\/a><\/li><li><a href=\"https:\/\/www.pqra.gr\/el\/quality-risk-management-after-ich-q9r1-formality-subjectivity-and-the-chapter-1-rewrite\/\">Quality Risk Management After ICH Q9(R1): Formality, Subjectivity and the Chapter 1 Rewrite<\/a><\/li><\/ul>\n<h2>How PQRA helps<\/h2>\n<p>PQRA aligns change control procedures with regulatory requirements, assesses the variation impact of planned changes, and helps companies sequence implementation with submissions and approvals.<\/p>\n<p><strong>Ready to talk it through?<\/strong> <a href=\"\/el\/contact\/\">Contact the PQRA team<\/a>.<\/p>","protected":false},"excerpt":{"rendered":"<p>A change that is well controlled on site can still create a compliance problem if nobody asked whether the marketing authorisation needs to be updated first. The purpose of change control Change control provides a structured way to evaluate, approve and implement changes to processes, equipment, materials, methods, systems and documents. ICH Q10 treats change [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":838,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"saved_in_kubio":false,"_swpsp_post_exclude":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-809","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Change Control in the Pharmaceutical Quality System: Linking Quality to Regulatory Impact - PQRA<\/title>\n<meta name=\"description\" content=\"A change that is well controlled on site can still create a compliance problem if nobody asked whether the marketing authorisation needs to be updated\u2026\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.pqra.gr\/el\/change-control-in-the-pharmaceutical-quality-system-linking-quality-to-regulatory-impact\/\" \/>\n<meta property=\"og:locale\" content=\"el_GR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Change Control in the Pharmaceutical Quality System: Linking Quality to Regulatory Impact - PQRA\" \/>\n<meta property=\"og:description\" content=\"A change that is well controlled on site can still create a compliance problem if nobody asked whether the marketing authorisation needs to be updated\u2026\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.pqra.gr\/el\/change-control-in-the-pharmaceutical-quality-system-linking-quality-to-regulatory-impact\/\" \/>\n<meta property=\"og:site_name\" content=\"PQRA\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-19T06:27:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-19T07:51:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.pqra.gr\/wp-content\/uploads\/2026\/10\/qms-change-control.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u03a3\u03c5\u03bd\u03c4\u03ac\u03c7\u03b8\u03b7\u03ba\u03b5 \u03b1\u03c0\u03cc\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u0395\u03ba\u03c4\u03b9\u03bc\u03ce\u03bc\u03b5\u03bd\u03bf\u03c2 \u03c7\u03c1\u03cc\u03bd\u03bf\u03c2 \u03b1\u03bd\u03ac\u03b3\u03bd\u03c9\u03c3\u03b7\u03c2\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 \u03bb\u03b5\u03c0\u03c4\u03ac\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/change-control-in-the-pharmaceutical-quality-system-linking-quality-to-regulatory-impact\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/change-control-in-the-pharmaceutical-quality-system-linking-quality-to-regulatory-impact\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/#\\\/schema\\\/person\\\/31e1a03125e7281efaddd7278681af2c\"},\"headline\":\"Change Control in the Pharmaceutical Quality System: Linking Quality to Regulatory Impact\",\"datePublished\":\"2026-10-19T06:27:10+00:00\",\"dateModified\":\"2026-10-19T07:51:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/change-control-in-the-pharmaceutical-quality-system-linking-quality-to-regulatory-impact\\\/\"},\"wordCount\":374,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/change-control-in-the-pharmaceutical-quality-system-linking-quality-to-regulatory-impact\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.pqra.gr\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/qms-change-control.png\",\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"el\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.pqra.gr\\\/change-control-in-the-pharmaceutical-quality-system-linking-quality-to-regulatory-impact\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/change-control-in-the-pharmaceutical-quality-system-linking-quality-to-regulatory-impact\\\/\",\"url\":\"https:\\\/\\\/www.pqra.gr\\\/change-control-in-the-pharmaceutical-quality-system-linking-quality-to-regulatory-impact\\\/\",\"name\":\"Change Control in the Pharmaceutical Quality System: Linking Quality to Regulatory Impact - PQRA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/change-control-in-the-pharmaceutical-quality-system-linking-quality-to-regulatory-impact\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/change-control-in-the-pharmaceutical-quality-system-linking-quality-to-regulatory-impact\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.pqra.gr\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/qms-change-control.png\",\"datePublished\":\"2026-10-19T06:27:10+00:00\",\"dateModified\":\"2026-10-19T07:51:25+00:00\",\"description\":\"A change that is well controlled on site can still create a compliance problem if nobody asked whether the marketing authorisation needs to be updated\u2026\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/change-control-in-the-pharmaceutical-quality-system-linking-quality-to-regulatory-impact\\\/#breadcrumb\"},\"inLanguage\":\"el\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.pqra.gr\\\/change-control-in-the-pharmaceutical-quality-system-linking-quality-to-regulatory-impact\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"el\",\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/change-control-in-the-pharmaceutical-quality-system-linking-quality-to-regulatory-impact\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.pqra.gr\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/qms-change-control.png\",\"contentUrl\":\"https:\\\/\\\/www.pqra.gr\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/qms-change-control.png\",\"width\":1200,\"height\":630},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/change-control-in-the-pharmaceutical-quality-system-linking-quality-to-regulatory-impact\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.pqra.gr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Change Control in the Pharmaceutical Quality System: Linking Quality to Regulatory Impact\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/#website\",\"url\":\"https:\\\/\\\/www.pqra.gr\\\/\",\"name\":\"PQRA\",\"description\":\"Your trusted partner in Pharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.pqra.gr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"el\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/#organization\",\"name\":\"PQRA\",\"url\":\"https:\\\/\\\/www.pqra.gr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"el\",\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.pqra.gr\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/pqra-logo-white.png\",\"contentUrl\":\"https:\\\/\\\/www.pqra.gr\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/pqra-logo-white.png\",\"width\":594,\"height\":362,\"caption\":\"PQRA\"},\"image\":{\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/#\\\/schema\\\/person\\\/31e1a03125e7281efaddd7278681af2c\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"el\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/656b750ec6bc02db9de84dc3080e82be722c7777ef23ff04d6e8e7a0ac541a45?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/656b750ec6bc02db9de84dc3080e82be722c7777ef23ff04d6e8e7a0ac541a45?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/656b750ec6bc02db9de84dc3080e82be722c7777ef23ff04d6e8e7a0ac541a45?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"sameAs\":[\"https:\\\/\\\/www.pqra.gr\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Change Control in the Pharmaceutical Quality System: Linking Quality to Regulatory Impact - PQRA","description":"A change that is well controlled on site can still create a compliance problem if nobody asked whether the marketing authorisation needs to be updated\u2026","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.pqra.gr\/el\/change-control-in-the-pharmaceutical-quality-system-linking-quality-to-regulatory-impact\/","og_locale":"el_GR","og_type":"article","og_title":"Change Control in the Pharmaceutical Quality System: Linking Quality to Regulatory Impact - PQRA","og_description":"A change that is well controlled on site can still create a compliance problem if nobody asked whether the marketing authorisation needs to be updated\u2026","og_url":"https:\/\/www.pqra.gr\/el\/change-control-in-the-pharmaceutical-quality-system-linking-quality-to-regulatory-impact\/","og_site_name":"PQRA","article_published_time":"2026-10-19T06:27:10+00:00","article_modified_time":"2026-10-19T07:51:25+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/www.pqra.gr\/wp-content\/uploads\/2026\/10\/qms-change-control.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"\u03a3\u03c5\u03bd\u03c4\u03ac\u03c7\u03b8\u03b7\u03ba\u03b5 \u03b1\u03c0\u03cc":"admin","\u0395\u03ba\u03c4\u03b9\u03bc\u03ce\u03bc\u03b5\u03bd\u03bf\u03c2 \u03c7\u03c1\u03cc\u03bd\u03bf\u03c2 \u03b1\u03bd\u03ac\u03b3\u03bd\u03c9\u03c3\u03b7\u03c2":"2 \u03bb\u03b5\u03c0\u03c4\u03ac"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.pqra.gr\/change-control-in-the-pharmaceutical-quality-system-linking-quality-to-regulatory-impact\/#article","isPartOf":{"@id":"https:\/\/www.pqra.gr\/change-control-in-the-pharmaceutical-quality-system-linking-quality-to-regulatory-impact\/"},"author":{"name":"admin","@id":"https:\/\/www.pqra.gr\/#\/schema\/person\/31e1a03125e7281efaddd7278681af2c"},"headline":"Change Control in the Pharmaceutical Quality System: Linking Quality to Regulatory Impact","datePublished":"2026-10-19T06:27:10+00:00","dateModified":"2026-10-19T07:51:25+00:00","mainEntityOfPage":{"@id":"https:\/\/www.pqra.gr\/change-control-in-the-pharmaceutical-quality-system-linking-quality-to-regulatory-impact\/"},"wordCount":374,"commentCount":0,"publisher":{"@id":"https:\/\/www.pqra.gr\/#organization"},"image":{"@id":"https:\/\/www.pqra.gr\/change-control-in-the-pharmaceutical-quality-system-linking-quality-to-regulatory-impact\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pqra.gr\/wp-content\/uploads\/2026\/10\/qms-change-control.png","articleSection":["Uncategorized"],"inLanguage":"el","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.pqra.gr\/change-control-in-the-pharmaceutical-quality-system-linking-quality-to-regulatory-impact\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.pqra.gr\/change-control-in-the-pharmaceutical-quality-system-linking-quality-to-regulatory-impact\/","url":"https:\/\/www.pqra.gr\/change-control-in-the-pharmaceutical-quality-system-linking-quality-to-regulatory-impact\/","name":"Change Control in the Pharmaceutical Quality System: Linking Quality to Regulatory Impact - PQRA","isPartOf":{"@id":"https:\/\/www.pqra.gr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.pqra.gr\/change-control-in-the-pharmaceutical-quality-system-linking-quality-to-regulatory-impact\/#primaryimage"},"image":{"@id":"https:\/\/www.pqra.gr\/change-control-in-the-pharmaceutical-quality-system-linking-quality-to-regulatory-impact\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pqra.gr\/wp-content\/uploads\/2026\/10\/qms-change-control.png","datePublished":"2026-10-19T06:27:10+00:00","dateModified":"2026-10-19T07:51:25+00:00","description":"A change that is well controlled on site can still create a compliance problem if nobody asked whether the marketing authorisation needs to be updated\u2026","breadcrumb":{"@id":"https:\/\/www.pqra.gr\/change-control-in-the-pharmaceutical-quality-system-linking-quality-to-regulatory-impact\/#breadcrumb"},"inLanguage":"el","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.pqra.gr\/change-control-in-the-pharmaceutical-quality-system-linking-quality-to-regulatory-impact\/"]}]},{"@type":"ImageObject","inLanguage":"el","@id":"https:\/\/www.pqra.gr\/change-control-in-the-pharmaceutical-quality-system-linking-quality-to-regulatory-impact\/#primaryimage","url":"https:\/\/www.pqra.gr\/wp-content\/uploads\/2026\/10\/qms-change-control.png","contentUrl":"https:\/\/www.pqra.gr\/wp-content\/uploads\/2026\/10\/qms-change-control.png","width":1200,"height":630},{"@type":"BreadcrumbList","@id":"https:\/\/www.pqra.gr\/change-control-in-the-pharmaceutical-quality-system-linking-quality-to-regulatory-impact\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.pqra.gr\/"},{"@type":"ListItem","position":2,"name":"Change Control in the Pharmaceutical Quality System: Linking Quality to Regulatory Impact"}]},{"@type":"WebSite","@id":"https:\/\/www.pqra.gr\/#website","url":"https:\/\/www.pqra.gr\/","name":"PQRA","description":"Your trusted partner in Pharma","publisher":{"@id":"https:\/\/www.pqra.gr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.pqra.gr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"el"},{"@type":"Organization","@id":"https:\/\/www.pqra.gr\/#organization","name":"PQRA","url":"https:\/\/www.pqra.gr\/","logo":{"@type":"ImageObject","inLanguage":"el","@id":"https:\/\/www.pqra.gr\/#\/schema\/logo\/image\/","url":"https:\/\/www.pqra.gr\/wp-content\/uploads\/2026\/07\/pqra-logo-white.png","contentUrl":"https:\/\/www.pqra.gr\/wp-content\/uploads\/2026\/07\/pqra-logo-white.png","width":594,"height":362,"caption":"PQRA"},"image":{"@id":"https:\/\/www.pqra.gr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.pqra.gr\/#\/schema\/person\/31e1a03125e7281efaddd7278681af2c","name":"admin","image":{"@type":"ImageObject","inLanguage":"el","@id":"https:\/\/secure.gravatar.com\/avatar\/656b750ec6bc02db9de84dc3080e82be722c7777ef23ff04d6e8e7a0ac541a45?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/656b750ec6bc02db9de84dc3080e82be722c7777ef23ff04d6e8e7a0ac541a45?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/656b750ec6bc02db9de84dc3080e82be722c7777ef23ff04d6e8e7a0ac541a45?s=96&d=mm&r=g","caption":"admin"},"sameAs":["https:\/\/www.pqra.gr"]}]}},"_links":{"self":[{"href":"https:\/\/www.pqra.gr\/el\/wp-json\/wp\/v2\/posts\/809","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pqra.gr\/el\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pqra.gr\/el\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pqra.gr\/el\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pqra.gr\/el\/wp-json\/wp\/v2\/comments?post=809"}],"version-history":[{"count":2,"href":"https:\/\/www.pqra.gr\/el\/wp-json\/wp\/v2\/posts\/809\/revisions"}],"predecessor-version":[{"id":860,"href":"https:\/\/www.pqra.gr\/el\/wp-json\/wp\/v2\/posts\/809\/revisions\/860"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pqra.gr\/el\/wp-json\/wp\/v2\/media\/838"}],"wp:attachment":[{"href":"https:\/\/www.pqra.gr\/el\/wp-json\/wp\/v2\/media?parent=809"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pqra.gr\/el\/wp-json\/wp\/v2\/categories?post=809"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pqra.gr\/el\/wp-json\/wp\/v2\/tags?post=809"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}